MLTX
MoonLake Immunotherapeutics · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders -9.1% ·
aandelenstroom -4.3% ·
netto nieuwe posities -10.0%
— formule
Brede distributie — dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 59 | +3 | 21.61M | $421.37M | +4 | −1 |
| Q1 2026 | 59 | +5 | 21.19M | $393.03M | +8 | −3 |
| Q4 2025 | 55 | +1 | 18.04M | $237.83M | +3 | −2 |
| Q3 2025 | 15 | +2 | 5.30M | $38.02M | +3 | −1 |
| Q2 2025 | 10 | -1 | 11.33M | $534.65M | +1 | −2 |
| Q1 2025 | 8 | 0 | 5.66M | $221.05M | +2 | −2 |
| Q4 2024 | 8 | 0 | 7.28M | $394.17M | +1 | −1 |
| Q3 2024 | 7 | 0 | 7.26M | $366.27M | — | — |
| Q2 2024 | 7 | — | 8.40M | $369.30M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 5.73M | — | $270.48M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 2.61M | -12.1% | $123.34M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.67M | +13.2% | $79.01M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.67M | +13.2% | $79.01M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | Marshall Wace ✦ | 529.21K | -17.4% | $24.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 10 | Marshall Wace ✦ | 529.21K | -17.4% | $24.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | BlackRock ✦ (passief) | 327.34K | — | $15.45M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Point72 Asset Management ✦ | 186.57K | Nieuw | $8.81M | 0.0% | New | 1 | SEC ↗ |
| 25 | The Vanguard Group ✦ (passief) | 120.87K | — | $5.71M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | The Vanguard Group ✦ (passief) | 120.87K | — | $5.71M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | The Vanguard Group ✦ (passief) | 120.87K | — | $5.71M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | The Vanguard Group ✦ (passief) | 120.87K | — | $5.71M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | State Street Global Advisors ✦ (passief) | 64.56K | -30.9% | $3.05M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 30 | Geode Capital Management ✦ (passief) | 59.55K | +0.9% | $2.81M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | Wellington Management ✦ | 21.39K | -33.5% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | Wellington Management ✦ | 21.39K | -33.5% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 33 | Wellington Management ✦ | 21.39K | -33.5% | $1.01M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $8.81M | 0.0% |
Verlaten
| Millennium Management | $13.45M | was 0.0% |
| Two Sigma Investments | $1.39M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 145 houders, 61.96M aandelen, $1.12B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.